1
|
Ning JJ, Zuo ZH, Yu ZD, Li XM, Qiao LN. [Safety of modified T-piece resuscitator versus nasal cannula oxygen in electronic bronchoscopy for infants: a prospective randomized controlled study]. ZHONGGUO DANG DAI ER KE ZA ZHI = CHINESE JOURNAL OF CONTEMPORARY PEDIATRICS 2024; 26:37-41. [PMID: 38269457 PMCID: PMC10817733 DOI: 10.7499/j.issn.1008-8830.2309027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 12/04/2023] [Indexed: 01/26/2024]
Abstract
OBJECTIVES To optimize the oxygen therapy regimens for infants with pulmonary diseases during bronchoscopy. METHODS A prospective randomized, controlled, and single-center clinical trial was conducted on 42 infants who underwent electronic bronchoscopy from July 2019 to July 2021. These infants were divided into a nasal cannula (NC) group and a modified T-piece resuscitator (TPR) group using a random number table. The lowest intraoperative blood oxygen saturation was recorded as the primary outcome, and intraoperative heart rate and respiratory results were recorded as the secondary outcomes. RESULTS Compared with the NC group, the modified TPR group had a significantly higher level of minimum oxygen saturation during surgery and a significantly lower incidence rate of hypoxemia (P<0.05). In the modified TPR group, there were 6 infants with mild hypoxemia, 2 with moderate hypoxemia, and 1 with severe hypoxemia, while in the NC group, there were 3 infants with mild hypoxemia, 5 with moderate hypoxemia, and 9 with severe hypoxemia (P<0.05). The modified TPR group had a significantly lower incidence rate of intraoperative respiratory rhythm abnormalities than the NC group (P<0.05), but there was no significant difference in the incidence rate of arrhythmias between the two groups (P>0.05). CONCLUSIONS Modified TPR can significantly reduce the risk of hypoxemia in infants with pulmonary diseases during electronic bronchoscopy, and TPR significantly decreases the severity of hypoxemia and the incidence of respiratory rhythm abnormalities compared with traditional NC.
Collapse
Affiliation(s)
- Jun-Jie Ning
- Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu 610041, China; National Health Commission Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Chengdu 610041, China (Qiao L-N, . cn)
| | - Zhi-Hui Zuo
- Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu 610041, China; National Health Commission Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Chengdu 610041, China (Qiao L-N, . cn)
| | - Zhi-Dong Yu
- Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu 610041, China; National Health Commission Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Chengdu 610041, China (Qiao L-N, . cn)
| | - Xue-Mei Li
- Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu 610041, China; National Health Commission Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Chengdu 610041, China (Qiao L-N, . cn)
| | | |
Collapse
|
2
|
Gao S, Wang T, Cao L, Li L, Yang S. Clinical effects of remimazolam alone or in combination with dexmedetomidine in patients receiving bronchoscopy and influences on postoperative cognitive function: a randomized-controlled trial. Int J Clin Pharm 2023; 45:137-145. [PMID: 36346544 DOI: 10.1007/s11096-022-01487-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 09/08/2022] [Indexed: 11/10/2022]
Abstract
BACKGROUND Remimazolam and dexmedetomidine are commonly used as sedatives. However, the effects and safety of remimazolam alone or in combination with dexmedetomidine have not been investigated. AIM We sought to investigate the clinical effects of remimazolam alone or in combination with dexmedetomidine in bronchoscopy, and their influence on cognitive function. METHOD Ninety eligible patients who underwent bronchoscopy under intravenous anesthesia were randomly divided into three groups: propofol control, remimazolam, and remimazolam plus dexmedetomidine. The primary outcome was the incidence of perioperative hypoxemia. Secondary outcomes included induction and maintenance doses of remimazolam, hemodynamic variables, scores for modified Observer's Assessment of Alertness/Sedation (MOAA/S), coughing, limb movement, incidence of adverse events, patient satisfaction, bronchoscopist satisfaction, incidence of post-operative cognitive dysfunction (POCD), time to loss of consciousness (LoC), and time to awake. RESULTS The incidence of hypoxemia, hypotension, and bronchoscopist satisfaction score were significantly decreased, and time to LoC and time to awake were markedly longer in the remimazolam and remimazolam plus dexmedetomidine groups than in the propofol control group (p < 0.05). The remimazolam group had significantly decreased induction and maintenance doses of remimazolam and a shorter time to LoC than the remimazolam plus dexmedetomidine group (p < 0.05). Scores for coughing, limb movement, MOAA/S, and post-operative patient satisfaction were comparable among the three groups. POCD was not induced in any of the groups. CONCLUSION Remimazolam is safe and effective for painless bronchoscopy, with a low incidence of adverse reactions, and exhibits a good synergistic effect with dexmedetomidine. TRIAL REGISTRATION This trial protocol had been registered on Chinese Clinical Trial Registry (ChiCTR2000041435, date: 2020 12 26.
Collapse
Affiliation(s)
- Shenqiang Gao
- Department of Anesthesiology, Taian City Central Hospital, Taishan District, No.29, Longtan Road, Taian, 271000, Shandong Province, China
| | - Tingting Wang
- Department of Anesthesiology, Taian City Central Hospital, Taishan District, No.29, Longtan Road, Taian, 271000, Shandong Province, China
| | - Li Cao
- Department of Anesthesiology, Taian City Central Hospital, Taishan District, No.29, Longtan Road, Taian, 271000, Shandong Province, China
| | - Linyan Li
- Department of Anesthesiology, Shandong First Medical University, Taian, 271016, Shandong Province, China
| | - Shengqiang Yang
- Department of Anesthesiology, Taian City Central Hospital, Taishan District, No.29, Longtan Road, Taian, 271000, Shandong Province, China.
| |
Collapse
|
3
|
Ning J. A new oxygen therapy support device for infant bronchoscopy? Pediatr Pulmonol 2022; 57:2863-2865. [PMID: 35932209 DOI: 10.1002/ppul.26105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Revised: 07/12/2022] [Accepted: 07/21/2022] [Indexed: 11/10/2022]
Affiliation(s)
- Junjie Ning
- Pediatric Intensive Care Unit, First People's Hospital of Zigong City, Zigong, Sichuan, 643000, China
| |
Collapse
|
4
|
Sharluyan A, Osona B, Frontera G, Brandstrup KB, Figuerola J, Sanz-Ruiz I, Salas A, Garrido B, Eva CG, Fernandez A, Peña-Zarza JA, Gil JA, Bover-Bauzà C, Sailer S. High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial. Pediatr Pulmonol 2021; 56:4001-4010. [PMID: 34506689 DOI: 10.1002/ppul.25655] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 08/21/2021] [Accepted: 08/25/2021] [Indexed: 11/09/2022]
Abstract
BACKGROUND Hypoxemia is the most frequent complication of fiberoptic bronchoscopy (FB) in children. Guidelines recommend oxygen supplementation and conventional nasal prongs (NC) are used for this purpose. The aim of this study was to evaluate if the use of high-flow nasal cannula therapy (HFNC) in children undergoing FB result in a lower incidence of hypoxemia than standard oxygen administration. METHODS Patients aged 1 month-16 years undergoing elective FB were included in a prospective randomized controlled, nonblinded, single-center clinical trial and randomly assigned to receive oxygen via NC or HFNC. Patients' baseline characteristics were recorded pre-bronchoscopy. The primary outcome was oxygen desaturation during the procedure defined as saturation less than 94%. RESULTS An intention to treat analysis for 53 patients receiving NC and 51 receiving HFNC, showed HFNC patients were less likely to have hypoxemia than were NC patients (p = .011), with an absolute risk reduction of 0.27 (95% confidence interval [CI]: 0.08-0.45) and a number needed to treat of 3.75 (95% CI: 2.22-12.04). Moderate hypoxemia (SpO2 ≥ 90% and <94%, and <60 s) was observed significantly less often with HFNC than with NC (p = .012). Severe hypoxemia (SpO2 < 90% and >30 s) was not different between groups. Patients undergoing bronchoalveolar lavage (BAL) presented fewer desaturations with HFNC (p = .0003). CONCLUSIONS HFNC offers optimized oxygenation during elective FB with a significant reduction in desaturations and can be considered for oxygen administration, especially when BAL is performed.
Collapse
Affiliation(s)
- Artur Sharluyan
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain.,Pediatric Multidisciplinary Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain
| | - Borja Osona
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain.,Pediatric Multidisciplinary Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.,Division of Pediatric Respiratory Medicine, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Guillem Frontera
- Clinical Trials and Methodological Support Platform, University Hospital Son Espases, Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain
| | - Kay Boris Brandstrup
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Joan Figuerola
- Pediatric Multidisciplinary Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.,Division of Pediatric Respiratory Medicine, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Isabel Sanz-Ruiz
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Alberto Salas
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain.,Pediatric Multidisciplinary Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain
| | - Beatriz Garrido
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Chocano-González Eva
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Andrea Fernandez
- Division of Pediatric Transport and Critical Care, Department of Pediatrics, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Jose Antonio Peña-Zarza
- Division of Pediatric Respiratory Medicine, University Hospital Son Espases, Palma de Mallorca, Spain.,Sleep Apneas and Hypopneas Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain
| | - Jose Antonio Gil
- Pediatric Multidisciplinary Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.,Division of Pediatric Respiratory Medicine, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Catalina Bover-Bauzà
- Pediatric Multidisciplinary Research Group of the Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.,Division of Pediatric Respiratory Medicine, University Hospital Son Espases, Palma de Mallorca, Spain
| | - Sebastian Sailer
- Department of Neonatology, Kepler University Hospital, Johannes Kepler University, Faculty of Medicine, Linz, Austria
| |
Collapse
|